The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Kim, Seong Jang ^a   Hwang, Sang Hyun ^a   Kim, In Joo ^a   Lee, Min Ki ^a   Lee, Chang Hun ^a   Lee, Sang Yull ^b   Lee, Eun Yup ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN A; APEX1 PROTEIN, HUMAN; DIAGNOSTIC AGENT; DNA; HIF1A PROTEIN, HUMAN; RADIOPHARMACEUTICAL AGENT; SLC2A1 PROTEIN, HUMAN; TUMOR MARKER; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TRANSPORT; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; ANOXIA; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSPECTIVE STUDY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; FLUORODEOXYGLUCOSE F18; GENOTYPE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953317588     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-69     Document Type: Article

References (30)

1. PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response. DE Heron RS Andrade S Beriwal RP Smith, Am J Clin Oncol 2008 31 352 362 10.1097/COC.0b013e318162f150 18845994
2. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. RS Brown JY Leung PV Kison KR Zasadny A Flint RL Wahl, J Nucl Med 1999 40 556 565 10210213
3. HIF-1 and tumor progression: pathophysiology and therapeutics. GL Semenza, Trends Mol Med 2002 8 62 67 10.1016/S1471-4914(02)02317-1 11927290
4. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. GL Semenza, Curr Opin Genet Dev 1998 8 588 594 10.1016/S0959-437X(98)80016-6 9794818
5. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. KL Talks H Turley KC Gatter PH Maxwell CW Pugh PJ Ratcliffe AL Harris, Am J Pathol 2000 157 411 421 10934146
6. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. H Zhong AM De Marzo E Laughner M Lim DA Hilton D Zagzag P Buechler WB Isaacs GL Semenza JW Simons, Cancer Res 1999 59 5830 5835 10582706
7. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. XS Fu E Choi GJ Bubley SP Balk, Prostate 2005 63 215 221 10.1002/pros.20190 15538748
8. C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. MI Koukourakis D Papazoglou A Giatromanolaki I Panagopoulos E Maltezos AL Harris KC Gatter E Sivridis, Lung Cancer 2006 53 257 262 10.1016/j.lungcan.2006.05.025 16837101
9. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. W Renner S Kotschan C Hoffmann B Obermayer-Pietsch E Pilger, J Vasc Res 2000 37 443 448 10.1159/000054076 11146397
10. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 CT) gene and colon cancer in Korea. SJ Bae JW Kim H Kang SG Hwang D Oh NK Kim, Anticancer Res 2008 28 1271 1276 18505065
11. The 936CT polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake. G Wolf RM Aigner G Schaffler U Langsenlehner W Renner H Samonigg B Yazdani-Biuki P Krippl, Breast Cancer Res Treat 2004 88 205 208 10.1007/s10549-004-0724-2 15609122
12. Going APE over ref-1. AR Evans M Limp-Foster MR Kelley, Mutat Res 2000 461 83 108 11018583
13. Base excision repair of DNA in mammalian cells. HE Krokan H Nilsen F Skorpen M Otterlei G Slupphaug, FEBS Lett 2000 476 73 77 10.1016/S0014-5793(00) 01674-4 10878254
14. Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. M Kasahara K Osawa K Yoshida A Miyaishi Y Osawa N Inoue A Tsutou Y Tabuchi K Tanaka M Yamamoto,, et al. J Exp Clin Cancer Res 2008 27 49 10.1186/1756-9966-27-49 18823566
15. Association of genetic polymorphism of the DNA base excision repair gene (APE-1 Asp/148 Glu) and HPV type (16/18) with the risk of cervix cancer in north Indian population. M Shekari RC Sobti DM Tamandani K Malekzadeh P Kaur V Suri, Cancer Biomark 2008 4 63 71 18503157
16. Alteration of APE1/ref-1 expression in non-small cell lung cancer: the implications of impaired extracellular superoxide dismutase and catalase antioxidant systems. DG Yoo YJ Song EJ Cho SK Lee JB Park JH Yu SP Lim JM Kim BH Jeon, Lung Cancer 2008 60 277 284 10.1016/j.lungcan.2007.10.015 18061304
17. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. A van Baardwijk C Dooms RJ van Suylen E Verbeken M Hochstenbag C Dehing-Oberije D Rupa S Pastorekova S Stroobants U Buell,, et al. Eur J Cancer 2007 43 1392 1398 10.1016/j.ejca.2007.03.027 17512190
18. Correlation of angiogenesis with (18)F-FMT and (18)F-FDG uptake in non-small cell lung cancer. K Kaira N Oriuchi K Shimizu T Ishikita T Higuchi H Imai N Yanagitani N Sunaga T Hisada T Ishizuka,, et al. Cancer Sci 2009 100 753 758 10.1111/j.1349-7006.2008.01077.x 19141127
19. A novel polymorphism in the 5' flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with Type 1 diabetes mellitus. AD Hodgkinson T Page BA Millward AG Demaine, J Diabetes Complications 2005 19 65 69 10.1016/j.jdiacomp.2004.07.002 15745834
20. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer. A Matakidou R el Galta EL Webb MF Rudd H Bridle GC the T Eisen RS Houlston, Hum Mol Genet 2007 16 2333 2340 10.1093/hmg/ddm190 17855454
21. Prognostic value of FDG uptake in early stage non-small cell lung cancer. FX Hanin M Lonneux J Cornet P Noirhomme C Coulon J Distexhe AJ Poncelet, Eur J Cardiothorac Surg 2008 33 819 823 10.1016/j.ejcts.2008.02.005 18374589
22. Tumor doubling time and prognostic assessment of patients with primary lung cancer. K Usuda Y Saito M Sagawa M Sato K Kanma S Takahashi C Endo Y Chen A Sakurada S Fujimura, Cancer 1994 74 2239 2244 10.1002/1097-0142(19941015)74: 8<2239::AID-CNCR28207408063.0.CO;2-P 7922975 (Pubitemid 24322277)
23. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. FG Duhaylongsod VJ Lowe EF Patz Jr AL Vaughn RE Coleman WG Wolfe, Ann Thorac Surg 1995 60 1348 1352 10.1016/0003-4975(95)00754-9 8526625
24. Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. ZH Liu TJ Guan ZH Chen LS Li, Kidney Int 1999 55 1843 1848 10.1046/j.1523-1755.1999.00449.x 10231446
25. Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. L Tarnow N Grarup T Hansen HH Parving O Pedersen, Nephrol Dial Transplant 2001 16 1653 1656 10.1093/ndt/16.8.1653 11477169
26. Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. W Grzeszczak DK Moczulski M Zychma E Zukowska-Szczechowska W Trautsolt I Szydlowska, Kidney Int 2001 59 631 636 10.1046/j.1523-1755.2001.059002631.x 11168944
27. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. ML Fishel Y He AM Reed H Chin-Sinex GD Hutchins MS Mendonca MR Kelley, DNA Repair 2008 7 177 186 10.1016/j.dnarep.2007. 09.008 17974506
28. Single nucleotide polymorphism in the hypoxia-inducible factor-1alpha gene in colorectal carcinoma. T Kuwai Y Kitadai S Tanaka T Kuroda T Ochiumi S Matsumura N Oue W Yasui M Kaneyasu K Tanimoto,, et al. Oncol Rep 2004 12 1033 1037 15492789
29. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer. R Zhai G Liu W Zhou L Su RS Heist TJ Lynch JC Wain K Asomaning X Lin DC Christiani, Clin Cancer Res 2008 14 612 617 10.1158/1078-0432.CCR-07-1655 18223238
30. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. RS Heist R Zhai G Liu W Zhou X Lin L Su K Asomaning TJ Lynch JC Wain DC Christiani, J Clin Oncol 2008 26 856 862 10.1200/JCO.2007.13.5947 18281657